Abbott Laboratories

Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report

The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More

Barron's Picks And Pans: AT&T, GE, Zynga And More

The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More

Barron's Picks And Pans: AT&T, GE, Zynga And More

Benzinga's Insider Buys Of The Week: Abbott Labs, Hain Celestial, Parsley Energy And More

Barron's Ranks The Best Mutual Fund Families

Benzinga's Insider Buys Of The Week: Abbott Labs, Hain Celestial, Parsley Energy And More

Barron's Ranks The Best Mutual Fund Families

Insiders Buy Abbott Laboratories Shares After Merger Deal Sours

Abbott Labs Salesman Commits Suicide, Cites Company Pressure To Hit Sales Targets

Abbott Laboratories Recent News

Short Interest In Abbott Labs And Baxter International Doubles

Mylan Is 'Comfortable Moving Forward' With Acquisition Of Sweden-Based Meda

5 Family-Friendly Employers For Working Parents

5 Top Dow Stocks With The Most Upside Potential

Market Wrap For April 21: S&P 500 Extends Winning Streak To Five Days, Dow & Nasdaq Also Positive

Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data

New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)

Earnings Expectations For The Week Of January 20: Microsoft, McDonald's, Netflix And More

UPDATE: Goldman Sachs Upgrades Abbott Laboratories; Growth Is Poised To Accelerate

Earnings Expectations for the Week of October 15

Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

Dr Faessel - 6-17-2011

Morgan Stanley Provided Color on Abbott Laboratories, Overweight

Wedbush Reports Solid Results But Fizzling Stocks For Abbott Labs

Morgan Stanley Maintains Overweight on Abbott Laboratories (ABT)

J.P. Morgan Lowers ABT Target To $55 From $60

Citigroup Lowers PT On Abbott Laboratories

Stocks Good for Guilty Holiday Diets

Goldman Sachs Decreases Price Target on Abbott Laboratories (ABT)

Abbott Laboratories' 3Q Preview

Rating: Buy Status Initiated for Abbott Laboratories (ABT)

Morgan Stanley's Equity Morning Summary